Golcadomide and Nivolumab in Patients With Non-Hodgkin Lymphoma With Refractory Disease After Chimeric Antigen T-cell Therapy
University of Pittsburgh
University of Pittsburgh
Juventas Cell Therapy Ltd.
ImmunityBio, Inc.
M.D. Anderson Cancer Center
University of Nebraska
Technical University of Munich
Gilead Sciences
Alliance for Clinical Trials in Oncology
RedHill Biopharma Limited
Western Regional Medical Center
Rigshospitalet, Denmark
Mayo Clinic
GlaxoSmithKline
M.D. Anderson Cancer Center
Charite University, Berlin, Germany